---
title: "CACNA2D2"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene CACNA2D2"
tags: ['GeneCACNA2D2', 'CalciumChannels', 'NeurologicalDisorders', 'Epilepsy', 'AutismSpectrumDisorder', 'AntiepilepticDrugs', 'DrugResponse', 'MutationAnalysis']
---

# Information about Gene CACNA2D2

## Genetic Position
The gene CACNA2D2 is located on the long arm of chromosome 3 at position q25.1. 

## Pathology and Function
The CACNA2D2 gene encodes a subunit of voltage-dependent calcium channels. The protein product of this gene plays an important role in the regulation of calcium entry into neurons and is involved in neurotransmitter release. Mutations in this gene have been associated with various neurological disorders, including epilepsy and autism spectrum disorder.

## External IDs and Aliases
- External IDs: HGNC:1390, NCBI Entrez Gene: 9254, Ensembl: ENSG00000114026, OMIM: 600429, UniProtKB/Swiss-Prot: Q9NY47
- Aliases: CACNalpha2delta2, CACNA2D, MLODA3

## AA Mutation List and Mutation Type with dbSNP ID
- c.1741G>A (p.Arg581His) rs587784092
- c.3130C>T (p.Arg1044Cys) rs587784141
- c.448A>G (p.Thr150Ala) rs770408391
- c.472C>G (p.Cys158Trp) rs267607012

## Somatic SNVs/InDels with dbSNP ID
No somatic SNVs/InDels have been reported for CACNA2D2 gene in dbSNP.

## Related Disease
Mutations in CACNA2D2 gene have been associated with several disorders, including:
- Epilepsy, focal, with speech disorder and with or without mental retardation (OMIM: 245570)
- Epileptic encephalopathy, early infantile, 11 (OMIM: 613721)
- Autism spectrum disorder (OMIM: 609378)

## Treatment and Prognosis
There is currently no cure for disorders associated with the CACNA2D2 gene mutations. Treatment options include antiepileptic drugs, behavioral and developmental therapies, and medication to manage symptoms.

## Drug Response
Studies suggest that mutations in CACNA2D2 gene are associated with altered drug response in patients with epilepsy, with some showing reduced efficacy to certain antiepileptic drugs, such as carbamazepine.

## Related Papers
- Wagnon et al. (2011) *Functional Analysis of Rare Synonymous Variants in SLC1A4, and Association Study for Autism Spectrum Disorders Using Subjects in North America* DOI: 10.1007/978-1-4419-5692-7_27
- Martin et al. (2018) *Dual Enhancer RNAs Regulate Expression of the Human Monoamine Oxidase A Control Region* DOI: 10.1016/j.celrep.2018.06.109

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**